Saved in:
| Main Authors: | Sun, Zenan, Abeysinghe, Rashmie, Li, Xiaojin, Hu, Xinyue, Cui, Licong, Zhang, Guo-Qiang, Bian, Jiang, Tao, Cui |
|---|---|
| Format: | Preprint |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2511.21724 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Alzheimer's Disease Common Data Element Ontology for Clinical Trials (AD-CDO)
by: Sun, Zenan
Published: (2026)
by: Sun, Zenan
Published: (2026)
$\texttt{AMEND++}$: Benchmarking Eligibility Criteria Amendments in Clinical Trials
by: Das, Trisha, et al.
Published: (2026)
by: Das, Trisha, et al.
Published: (2026)
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis
by: An Outtier, et al.
Published: (2024)
by: An Outtier, et al.
Published: (2024)
Editorial: Striking the Right Balance for Eligibility Criteria for Clinical Trials in Inflammatory Bowel Disease
by: Virginia Solitano, et al.
Published: (2025)
by: Virginia Solitano, et al.
Published: (2025)
Self-explainable Graph Neural Network for Alzheimer's Disease And Related Dementias Risk Prediction
by: Hu, Xinyue, et al.
Published: (2023)
by: Hu, Xinyue, et al.
Published: (2023)
TrialCompass: Visual Analytics for Enhancing the Eligibility Criteria Design of Clinical Trials
by: Sheng, Rui, et al.
Published: (2025)
by: Sheng, Rui, et al.
Published: (2025)
Exploring the Generalization of Cancer Clinical Trial Eligibility Classifiers Across Diseases
by: Yang, Yumeng, et al.
Published: (2024)
by: Yang, Yumeng, et al.
Published: (2024)
Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
by: Benz, Luke, et al.
Published: (2024)
by: Benz, Luke, et al.
Published: (2024)
Advancing Biomedicine with Graph Representation Learning: Recent Progress, Challenges, and Future Directions
by: Li, Fang, et al.
Published: (2023)
by: Li, Fang, et al.
Published: (2023)
The Clinical Trials Landscape for Alzheimer's Disease
by: Guoping Shen, et al.
Published: (2025)
by: Guoping Shen, et al.
Published: (2025)
Systematic Literature Review on Clinical Trial Eligibility Matching
by: Sharif, Muhammad Talha, et al.
Published: (2025)
by: Sharif, Muhammad Talha, et al.
Published: (2025)
A Comparative Study of Recent Large Language Models on Generating Hospital Discharge Summaries for Lung Cancer Patients
by: Li, Yiming, et al.
Published: (2024)
by: Li, Yiming, et al.
Published: (2024)
Associations Between Alzheimer’s Disease and Obesity: Clinical Trials of NA‐831 for AD and NA‐931 for Obesity
by: Lloyd Tran, et al.
Published: (2024)
by: Lloyd Tran, et al.
Published: (2024)
EXPLORING THE DIVERGENCE OF FUNCTIONAL AND EVOLUTIONAL INTERACTIONS BETWEEN FUNGI AND BACTERIA
by: Abeysinghe, Gayan
Published: (2023)
by: Abeysinghe, Gayan
Published: (2023)
Most Patients Attending a Geriatrician‐Led Memory Clinic are Not Eligible for Alzheimer's Disease‐Modifying Drugs
by: Brendan Flanagan, et al.
Published: (2025)
by: Brendan Flanagan, et al.
Published: (2025)
Prompting Large Language Models for Clinical Temporal Relation Extraction
by: He, Jianping, et al.
Published: (2024)
by: He, Jianping, et al.
Published: (2024)
Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis
by: Zhao, Yao, et al.
Published: (2026)
by: Zhao, Yao, et al.
Published: (2026)
The ALERT Score: A Clinical Tool to Enrich for Trial‐Eligible Liver Fat Content in MASH and MASLD Clinical Trials
by: Magdalena Nowak, et al.
Published: (2025)
by: Magdalena Nowak, et al.
Published: (2025)
Drain Site Herniation of the Vermiform Appendix: A Rare Complication Following Laparotomy
by: Abeysinghe AHMGB1*, Jayasooriya HK2, Abeysinghe AHMCD3
Published: (2026)
by: Abeysinghe AHMGB1*, Jayasooriya HK2, Abeysinghe AHMCD3
Published: (2026)
Rapid Progressors in Alzheimer's Disease: Implications for Symptomatic Clinical Trial Design
by: Madison Shyer, et al.
Published: (2025)
by: Madison Shyer, et al.
Published: (2025)
Warmth of the welcome: Immigration and local housing price dynamics
by: Xun Bian, et al.
Published: (2025)
by: Xun Bian, et al.
Published: (2025)
SiteRx AI‐Enabled Clinical Intelligence Platform Delivers Superior Amyloid PET Conversion in Early Alzheimer’s Disease (AD) Trial
by: Erin Beck, et al.
Published: (2024)
by: Erin Beck, et al.
Published: (2024)
Lower Risk of Alzheimer’s Disease and Related Dementias associated with Angiotensin Receptor II Blockers (ARBs) treatment for individuals with Hypertension in High‐volume Claims Data
by: Sori Kim Lundin, et al.
Published: (2024)
by: Sori Kim Lundin, et al.
Published: (2024)
Neuroimaging in Atypical AD: Considerations for Clinical Trials
by: Jennifer L. Whitwell
Published: (2025)
by: Jennifer L. Whitwell
Published: (2025)
The Challenges of Evaluating LLM Applications: An Analysis of Automated, Human, and LLM-Based Approaches
by: Abeysinghe, Bhashithe, et al.
Published: (2024)
by: Abeysinghe, Bhashithe, et al.
Published: (2024)
AD-GPT: Large Language Models in Alzheimer's Disease
by: Liu, Ziyu, et al.
Published: (2025)
by: Liu, Ziyu, et al.
Published: (2025)
Reply to Williams et al.: Fair and Safe Eligibility Criteria for Women's Sport
by: Ross Tucker, et al.
Published: (2024)
by: Ross Tucker, et al.
Published: (2024)
Sex Differences in Disc Golf Performance: Implications for Eligibility Criteria for Women's Competitions
by: Tommy R. Lundberg, et al.
Published: (2025)
by: Tommy R. Lundberg, et al.
Published: (2025)
Clinical Trials Ontology Engineering with Large Language Models
by: Çakır, Berkan
Published: (2024)
by: Çakır, Berkan
Published: (2024)
Feasibility of Identifying Aerobic‐Fitness Responses to Aerobic Exercise in Alzheimer's Disease: The FIT‐AD SMART Trial
by: Fang Yu, et al.
Published: (2025)
by: Fang Yu, et al.
Published: (2025)
Estimating Potential Eligibility for Disease Modifying Therapies for Alzheimer’s Disease Using Population‐Based Data in Alberta, Canada
by: Mohammad Z I Chowdhury, et al.
Published: (2024)
by: Mohammad Z I Chowdhury, et al.
Published: (2024)
An Ontology for Representing Curriculum and Learning Material
by: Christou, Antrea, et al.
Published: (2025)
by: Christou, Antrea, et al.
Published: (2025)
A Real‐World Data‐Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B‐Cell Lymphoma Patients
by: Jelena Jelicic, et al.
Published: (2024)
by: Jelena Jelicic, et al.
Published: (2024)
Temporal Subtyping of Alzheimer's Disease Using Medical Conditions Preceding Alzheimer's Disease Onset in Electronic Health Records
by: He, Zhe, et al.
Published: (2022)
by: He, Zhe, et al.
Published: (2022)
Robust Causal Inference for EHR-based Studies of Point Exposures with Missingness in Eligibility Criteria
by: Benz, Luke, et al.
Published: (2025)
by: Benz, Luke, et al.
Published: (2025)
MÉTODO SIMPLIFICADO PARA DETERMINAR LA CURVA DE DISOCIACIÓN DE OXÍGENO (CDO)
by: Edgar CRISTANCHO
Published: (2019)
by: Edgar CRISTANCHO
Published: (2019)
Perfectly Fitting CDO Prices Across Tranches: A Theoretical Framework with Efficient Algorithms
by: Bu, Lan, et al.
Published: (2026)
by: Bu, Lan, et al.
Published: (2026)
Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Clinical Trial
by: Davangere P. Devanand, et al.
Published: (2025)
by: Davangere P. Devanand, et al.
Published: (2025)
Identifying Problematic Subjects Entering Clinical Trials in Early Alzheimer’s Disease
by: Alan Kott, et al.
Published: (2025)
by: Alan Kott, et al.
Published: (2025)
Impacts of Informant Replacement in Industry‐Sponsored Alzheimer’s Disease Clinical Trials
by: Mikaela K Nishida, et al.
Published: (2024)
by: Mikaela K Nishida, et al.
Published: (2024)
Similar Items
-
Alzheimer's Disease Common Data Element Ontology for Clinical Trials (AD-CDO)
by: Sun, Zenan
Published: (2026) -
$\texttt{AMEND++}$: Benchmarking Eligibility Criteria Amendments in Clinical Trials
by: Das, Trisha, et al.
Published: (2026) -
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis
by: An Outtier, et al.
Published: (2024) -
Editorial: Striking the Right Balance for Eligibility Criteria for Clinical Trials in Inflammatory Bowel Disease
by: Virginia Solitano, et al.
Published: (2025) -
Self-explainable Graph Neural Network for Alzheimer's Disease And Related Dementias Risk Prediction
by: Hu, Xinyue, et al.
Published: (2023)